Same Class, Different Risk? Dapagliflozin versus Empagliflozin and Genitourinary Safety in Heart Failure with Preserved Ejection Fraction: A Retrospective Comparative Cohort Study
Authors
Razvan Alexandru Danau
Urology Department, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Cardiology and Urology Department, Clinical Hospital “Prof. Dr. Th. Burghele”, Bucharest, Romania
Madalina Andreea Munteanu
Internal Medicine and Cardiology Department, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Minerva Muraru
Internal Medicine and Cardiology Department, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Camelia Nicolae
Internal Medicine and Cardiology Department, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Cardiology and Urology Department, Clinical Hospital “Prof. Dr. Th. Burghele”, Bucharest, Romania
Gabriel Predoiu
Urology Department, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Cardiology and Urology Department, Clinical Hospital “Prof. Dr. Th. Burghele”, Bucharest, Romania
Andreea Bardan
Urology Department, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Viorel Jinga
Urology Department, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Cardiology and Urology Department, Clinical Hospital “Prof. Dr. Th. Burghele”, Bucharest, Romania
DOI: https://doi.org/10.2478/rjim-2026-0024 | Journal eISSN: 2501-062X (formerly 1220-4749) | Journal ISSN: 1220-4749
Language: English, Romanian
Submitted on: Aug 18, 2026
Published on: Oct 26, 2026
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2026 Razvan Alexandru Danau, Madalina Andreea Munteanu, Minerva Muraru, Camelia Nicolae, Gabriel Predoiu, Andreea Bardan, Viorel Jinga, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.